Patents by Inventor Bruce Shutts
Bruce Shutts has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20190240252Abstract: The present invention relates to crosslinked polyamine particles and/or pharmaceutical compositions comprising, at least in part, crosslinked polyamine particles and aggregates of such particles (including cured aggregates of crosslinked polyamine particles). The compositions may be in the form of tablets comprising, for example, particles larger than 500 ?m, and used for treating patients, for example, patients with hyperphosphatemia.Type: ApplicationFiled: February 4, 2019Publication date: August 8, 2019Inventors: Stephen Randall HOLMES-FARLEY, David J. HARRIS, Steven C. POLOMOSCANIK, Adnan SALAMEH, Bruce SHUTTS, Richard SILVA, Pradeep K. DHAL, Lynne SOLE
-
Publication number: 20170152347Abstract: Amide compounds, amide polymers, compositions including amide compounds and amide polymers may be used to bind target ions, such as phosphorous-containing compounds in the gastrointestinal tract of animals. In some cases, amide compounds and amide polymers may include a core derived from an amide polyol and an organic polyacid or ester.Type: ApplicationFiled: November 9, 2016Publication date: June 1, 2017Inventors: Pradeep K. DHAL, David J. HARRIS, Stephen Randall HOLMES-FARLEY, Chad C. HUVAL, Vitaly NIVOROZHKIN, Bruce SHUTTS
-
Publication number: 20160158275Abstract: The present invention relates to crosslinked polyamine particles and/or pharmaceutical compositions comprising, at least in part, crosslinked polyamine particles and aggregates of such particles (including cured aggregates of crosslinked polyamine particles). The compositions may be in the form of tablets comprising, for example, particles larger than 500 ?m, and used for treating patients, for example, patients with hyperphosphatemia.Type: ApplicationFiled: December 14, 2015Publication date: June 9, 2016Inventors: Stephen Randall HOLMES-FARLEY, David J. HARRIS, Steven C. POLOMOSCANIK, Adnan SALAMEH, Bruce SHUTTS, Richard SILVA, Pradeep K. DHAL, Lynne SOLE
-
Publication number: 20150321996Abstract: Amide compounds, amide polymers, compositions including amide compounds and amide polymers may be used to bind target ions, such as phosphorous-containing compounds in the gastrointestinal tract of animals. In some cases, amide compounds and amide polymers may include a core derived from an amide polyol and an organic polyacid or ester.Type: ApplicationFiled: May 21, 2015Publication date: November 12, 2015Inventors: Pradeep K. DHAL, David J. HARRIS, Stephen Randall HOLMES-FARLEY, Chad C. HUVAL, Vitaly NIVOROZHKIN, Bruce SHUTTS
-
Patent number: 9066972Abstract: Amide compounds, amide polymers, compositions including amide compounds and amide polymers may be used to bind target ions, such as phosphorous-containing compounds in the gastrointestinal tract of animals. In some cases, amide compounds and amide polymers may include a core derived from an amide polyol and an organic polyacid or ester.Type: GrantFiled: April 24, 2014Date of Patent: June 30, 2015Assignee: Genzyme CorporationInventors: Pradeep K. Dhal, David J. Harris, Stephen Randall Holmes-Farley, Chad C. Huval, Vitaly Nivorozhkin, Bruce Shutts
-
Patent number: 8900560Abstract: Amide compounds, amide polymers, compositions including amide compounds and amide polymers may be used to bind target ions, such as phosphorous-containing compounds in the gastrointestinal tract of animals. In some cases, amide compounds and amide polymers may include a core derived from an amide polyol and an organic polyacid or ester.Type: GrantFiled: March 22, 2013Date of Patent: December 2, 2014Assignee: Genzyme CorporationInventors: Pradeep K. Dhal, David J. Harris, Stephen Randall Holmes-Farley, Chad C. Huval, Vitaly Nivorozhkin, Bruce Shutts
-
Publication number: 20140322319Abstract: The present invention relates to crosslinked polyamine particles and/or pharmaceutical compositions comprising, at least in part, crosslinked polyamine particles and aggregates of such particles (including cured aggregates of crosslinked polyamine particles). The compositions may be in the form of tablets comprising, for example, particles larger than 500 ?m particles and used for treating patients, for example, patients with hyperphosphatemia.Type: ApplicationFiled: April 17, 2014Publication date: October 30, 2014Applicant: GENZYME CORPORATIONInventors: Stephen Randall Holmes-Farley, David J. HARRIS, Steven C. POLOMOSCANIK, Adnan SALAMEH, Bruce SHUTTS, Richard SILVA, Pradeep K. DHAL, Lynne SOLE
-
Publication number: 20140235724Abstract: Amide compounds, amide polymers, compositions including amide compounds and amide polymers may be used to bind target ions, such as phosphorous-containing compounds in the gastrointestinal tract of animals. In some cases, amide compounds and amide polymers may include a core derived from an amide polyol and an organic polyacid or ester.Type: ApplicationFiled: April 24, 2014Publication date: August 21, 2014Applicant: GENZYME CORPORATIONInventors: Pradeep K. DHAL, David J. HARRIS, Stephen Randall HOLMES-FARLEY, Chad C. HUVAL, Vitaly NIVOROZHKIN, Bruce SHUTTS
-
Publication number: 20130251667Abstract: Amide compounds, amide polymers, compositions including amide compounds and amide polymers may be used to bind target ions, such as phosphorous-containing compounds in the gastrointestinal tract of animals. In some cases, amide compounds and amide polymers may include a core derived from an amide polyol and an organic polyacid or ester.Type: ApplicationFiled: March 22, 2013Publication date: September 26, 2013Applicant: SANOFIInventors: Pradeep K. DHAL, David J. HARRIS, Stephen Randall HOLMES-FARLEY, Chad C. HUVAL, Vitaly NIVOROZHKIN, Bruce SHUTTS
-
Patent number: 8425887Abstract: Amide compounds, amide polymers, compositions including amide compounds and amide polymers may be used to bind target ions, such as phosphorous-containing compounds in the gastrointestinal tract of animals. In some cases, amide compounds and amide polymers may include a core derived from an amide polyol and an organic polyacid or ester.Type: GrantFiled: September 26, 2007Date of Patent: April 23, 2013Assignee: Genzyme CorporationInventors: Pradeep K. Dhal, David J. Harris, Stephen Randall Holmes-Farley, Chad C. Huval, Vitaly Nivorozhkin, Bruce Shutts
-
Publication number: 20110142952Abstract: This invention relates to crosslinked amine-containing polymers for binding compounds or ions, and more specifically relates to pharmaceutically acceptable compositions for binding compounds or ions that include crosslinked amine-containing polymers. The pharmaceutically acceptable composition includes, for example, crosslinked polyamine particles, or pharmaceutically acceptable salts thereof, having a particle size distribution wherein greater than 10 vol. % of the particles have a particle size greater than 500 ?m.Type: ApplicationFiled: June 17, 2009Publication date: June 16, 2011Inventors: David J. Harris, Stephen Randall Holmes-Farley, Steven C. Polomoscanlk, Adnan Salameh, Bruce Shutts, Richard Silva
-
Publication number: 20100069500Abstract: Amide compounds, amide polymers, compositions including amide compounds and amide polymers may be used to bind target ions, such as phosphorous-containing compounds in the gastrointestinal tract of animals. In some cases, amide compounds and amide polymers may include a core derived from an amide polyol and an organic polyacid or ester.Type: ApplicationFiled: September 26, 2007Publication date: March 18, 2010Applicant: GENZYME CORPORATIONInventors: Pradeep K. Dhal, David J. Harris, Stephen Randall Holmes-Farley, Chad C. Huval, Vitaly Nivorozhkin, Bruce Shutts
-
Publication number: 20090155368Abstract: The present invention relates to crosslinked polyamine particles and/or pharmaceutical compositions comprising, at least in part, crosslinked polyamine particles and aggregates of such particles (including cured aggregates of crosslinked polyamine particles). The compositions may be in the form of tablets comprising, for example, particles larger than 500 ?m, and used for treating patients, for example, patients with hyperphosphatemia.Type: ApplicationFiled: December 12, 2008Publication date: June 18, 2009Applicant: Genzyme CorporationInventors: Stephen Randall Holmes-Farley, David J. Harris, Steven C. Polomoscanik, Adnan Salameh, Bruce Shutts, Richard Silva, Pradeep K. Dhal, Lynne Sole
-
Patent number: 6954144Abstract: A water pit transponder assembly includes a housing with multiple sections including top, main and bottom sections snap latched together connected to a water meter. A circuit board transponder in the housing includes a controller, a transmitter, a receiver and tamper detection software connected to antennas. An encoder is connected to the water meter, and batteries provide power to operate the assembly. The transponder sends and receives at different frequencies through different antennas and is protected from environmental corrosion by being encapsulated in a get inside the housing.Type: GrantFiled: May 30, 2003Date of Patent: October 11, 2005Assignee: AMCO Automated Systems, Inc.Inventors: Eric Kiser, Steve Murray, Bruce Shutts